INS and fatty liver disease: Coherently with such fact, recent studies addressed ERK1 knockout mice having a weight gain and insulin resistance, while ERK2 liver-specific knockout mice also developed hepatic steatosis, glucose intolerance, and diminished insulin sensitivity [9,10].